177 related articles for article (PubMed ID: 36619217)
21. The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review.
Van Paemel R; Vlug R; De Preter K; Van Roy N; Speleman F; Willems L; Lammens T; Laureys G; Schleiermacher G; Tytgat GAM; Astrahantseff K; Deubzer H; De Wilde B
Eur J Pediatr; 2020 Feb; 179(2):191-202. PubMed ID: 31897843
[TBL] [Abstract][Full Text] [Related]
22. Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins.
Božović A; Kulasingam V
Clin Biochem; 2013 Apr; 46(6):444-55. PubMed ID: 23041077
[TBL] [Abstract][Full Text] [Related]
23. Immunosuppressant therapeutic drug monitoring by LC-MS/MS: workflow optimization through automated processing of whole blood samples.
Marinova M; Artusi C; Brugnolo L; Antonelli G; Zaninotto M; Plebani M
Clin Biochem; 2013 Nov; 46(16-17):1723-7. PubMed ID: 24012696
[TBL] [Abstract][Full Text] [Related]
24. Multiplexed Liquid Chromatography-Multiple Reaction Monitoring Mass Spectrometry Quantification of Cancer Signaling Proteins.
Chen Y; Fisher KJ; Lloyd M; Wood ER; Coppola D; Siegel E; Shibata D; Chen YA; Koomen JM
Methods Mol Biol; 2017; 1647():19-45. PubMed ID: 28808993
[TBL] [Abstract][Full Text] [Related]
25. A proteomic signature of ovarian cancer tumor fluid identified by highthroughput and verified by targeted proteomics.
Poersch A; Grassi ML; Carvalho VP; Lanfredi GP; Palma CS; Greene LJ; de Sousa CB; Carrara HHA; Candido Dos Reis FJ; Faça VM
J Proteomics; 2016 Aug; 145():226-236. PubMed ID: 27222041
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
27. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.
Kennedy JJ; Whiteaker JR; Kennedy LC; Bosch DE; Lerch ML; Schoenherr RM; Zhao L; Lin C; Chowdhury S; Kilgore MR; Allison KH; Wang P; Hoofnagle AN; Baird GS; Paulovich AG
Clin Chem; 2021 Jul; 67(7):1008-1018. PubMed ID: 34136904
[TBL] [Abstract][Full Text] [Related]
28. The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.
Wang H; Shi T; Qian WJ; Liu T; Kagan J; Srivastava S; Smith RD; Rodland KD; Camp DG
Expert Rev Proteomics; 2016; 13(1):99-114. PubMed ID: 26581546
[TBL] [Abstract][Full Text] [Related]
29. Development and Provisional Validation of a Multiplex LC-MRM-MS Test for Timely Kidney Injury Detection in Urine.
van Duijl TT; Ruhaak LR; Smit NPM; Pieterse MM; Romijn FPHTM; Dolezal N; Drijfhout JW; de Fijter JW; Cobbaert CM
J Proteome Res; 2021 Dec; 20(12):5304-5314. PubMed ID: 34735145
[TBL] [Abstract][Full Text] [Related]
30. Comparison of Quantitative Mass Spectrometry Platforms for Monitoring Kinase ATP Probe Uptake in Lung Cancer.
Hoffman MA; Fang B; Haura EB; Rix U; Koomen JM
J Proteome Res; 2018 Jan; 17(1):63-75. PubMed ID: 29164889
[TBL] [Abstract][Full Text] [Related]
31. Accurate quantification of 5 German cockroach (GCr) allergens in complex extracts using multiple reaction monitoring mass spectrometry (MRM MS).
Mindaye ST; Spiric J; David NA; Rabin RL; Slater JE
Clin Exp Allergy; 2017 Dec; 47(12):1661-1670. PubMed ID: 28756650
[TBL] [Abstract][Full Text] [Related]
32. Pathology-Driven Comprehensive Proteomic Profiling of the Prostate Cancer Tumor Microenvironment.
Staunton L; Tonry C; Lis R; Espina V; Liotta L; Inzitari R; Bowden M; Fabre A; O'Leary J; Finn SP; Loda M; Pennington SR
Mol Cancer Res; 2017 Mar; 15(3):281-293. PubMed ID: 28057717
[TBL] [Abstract][Full Text] [Related]
33. Multiple reaction monitoring with multistage fragmentation (MRM3) detection enhances selectivity for LC-MS/MS analysis of plasma free metanephrines.
Wright MJ; Thomas RL; Stanford PE; Horvath AR
Clin Chem; 2015 Mar; 61(3):505-13. PubMed ID: 25605684
[TBL] [Abstract][Full Text] [Related]
34. Translational value of liquid chromatography coupled with tandem mass spectrometry-based quantitative proteomics for in vitro-in vivo extrapolation of drug metabolism and transport and considerations in selecting appropriate techniques.
Al Feteisi H; Achour B; Rostami-Hodjegan A; Barber J
Expert Opin Drug Metab Toxicol; 2015; 11(9):1357-69. PubMed ID: 26108733
[TBL] [Abstract][Full Text] [Related]
35. The Stroma Liquid Biopsy Panel Contains a Stromal-Epithelial Gene Signature Ratio That Is Associated with the Histologic Tumor-Stroma Ratio and Predicts Survival in Colon Cancer.
Ravensbergen CJ; Kuruc M; Polack M; Crobach S; Putter H; Gelderblom H; Roy D; Tollenaar RAEM; Mesker WE
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008327
[TBL] [Abstract][Full Text] [Related]
36. LC-MS/MS-based quantification of efflux transporter proteins at the BBB.
Gomez-Zepeda D; Taghi M; Smirnova M; Sergent P; Liu WQ; Chhuon C; Vidal M; Picard M; Thioulouse E; Broutin I; Guerrera IC; Scherrmann JM; Parmentier Y; Decleves X; Menet MC
J Pharm Biomed Anal; 2019 Feb; 164():496-508. PubMed ID: 30453156
[TBL] [Abstract][Full Text] [Related]
37. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease.
Sanda M; Pompach P; Brnakova Z; Wu J; Makambi K; Goldman R
Mol Cell Proteomics; 2013 May; 12(5):1294-305. PubMed ID: 23389048
[TBL] [Abstract][Full Text] [Related]
38. Advances in quantifying apolipoproteins using LC-MS/MS technology: implications for the clinic.
van den Broek I; Sobhani K; Van Eyk JE
Expert Rev Proteomics; 2017 Oct; 14(10):869-880. PubMed ID: 28870113
[TBL] [Abstract][Full Text] [Related]
39. Mass spectrometric quantification of urinary human liver fatty acid binding protein in renal transplant recipients.
Ozcan F; Akbas H; Kırac E; Suleymanlar G; Aslan M; Yucel G
Rapid Commun Mass Spectrom; 2016 Mar; 30(5):603-10. PubMed ID: 27043149
[TBL] [Abstract][Full Text] [Related]
40. Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patients.
Remily-Wood ER; Benson K; Baz RC; Chen YA; Hussein M; Hartley-Brown MA; Sprung RW; Perez B; Liu RZ; Yoder SJ; Teer JK; Eschrich SA; Koomen JM
Proteomics Clin Appl; 2014 Oct; 8(9-10):783-95. PubMed ID: 24723328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
